0

Crisaborole

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP906673243
CAS906673-24-3
Structure
MDL NumberMFCD17169940
Molecular Weight251.05
Description≥98% (HPLC)
SolubilityDMSO: 10 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditionsroom temp
1

Biological Therapies for Atopic Dermatitis: An Update

Diana Deleanu, Irena Nedelea

Exp Ther Med. 2019 Feb;17(2):1061-1067.

PMID: 30679974

1

Crisaborole 2% Ointment (Eucrisa) for Atopic Dermatitis

Taylor Evart Woo, Paul Kuzel

Skin Therapy Lett. 2019 Mar;24(2):4-6.

PMID: 30970204

1

Crisaborole and Atopic Dermatitis Skin Biomarkers: An Intrapatient Randomized Trial

Robert Bissonnette, Ana B Pavel, Aisleen Diaz, John L Werth, Chuanbo Zang, Ivana Vranic, Vivek S Purohit, Michael A Zielinski, Bonnie Vlahos, Yeriel D Estrada, Etienne Saint-Cyr Proulx, William C Ports, etc.

J Allergy Clin Immunol. 2019 Nov;144(5):1274-1289.

PMID: 31419544

1

Efficacy and Safety of Crisaborole Ointment, a Novel, Nonsteroidal Phosphodiesterase 4 (PDE4) Inhibitor for the Topical Treatment of Atopic Dermatitis (AD) in Children and Adults

Amy S Paller, Wynnis L Tom, Mark G Lebwohl, Robin L Blumenthal, Mark Boguniewicz, Robert S Call, Lawrence F Eichenfield, Douglass W Forsha, William C Rees, Eric L Simpson, Mary C Spellman, Linda F Stein Gold, etc.

J Am Acad Dermatol. 2016 Sep;75(3):494-503.e6.

PMID: 27417017

1

What's New in Atopic Dermatitis

Yael Renert-Yuval, Emma Guttman-Yassky

Dermatol Clin. 2019 Apr;37(2):205-213.

PMID: 30850043

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode